News

Genistein — the most-studied isoflavone in the phytoestrogen family — anchors a growing number of women's health and bone-support supplements. But sourcing it well comes down to knowing exactly what "genistein 98%" means, how it differs from the daidzein-rich soy isoflavones many buyers already use, and how to confirm purity on a COA. This guide covers the specifications that matter, how genistein is positioned in the market, and a checklist for vetting a Sophora Japonica Extract supplier. 1. Genistein vs Daidzein: Two Phytoestrogens, Different Roles Genistein and daidzein are the two best-known isoflavones — plant compounds that share a similar structure and both act as phytoestrogens. Most buyers first meet them together, because soy isoflavones are a mix of the two (plus smaller amounts of glycitein). That familiarity creates a common sourcing mistake: assuming every isoflavone ingredient is a blend. A Sophora Japonica Bud Extract standardized to genistein 98% is a different material — it delivers a single, high-purity isoflavone rather than a daidzein-containing mixture. If your formula or label is built around genistein specifically, this distinction is the difference between a clean single-compound spec and a blend that quietly shifts your label math. Here is the practical takeaway for sourcing: Soy isoflavones = genistein + daidzein (+ glycitein) — a total-isoflavone blend. Sophora japonica genistein = single-compound genistein, available up to 98% purity. If you need genistein on the label, buy genistein — not a blend that happens to contain some. 2. Key Specifications: Genistein 98% and Sophora Japonica Flavonoids Genistein is available in high-purity grades, most commonly 98%. Taking Justen's Natural Sophora Japonica Flower Extract Genistein 98% (SJE058) as a reference, here is what a complete spec looks like: Parameter Specification Method Genistein content ≥98.0% HPLC Identification Positive TLC Appearance Off-white powder Visual Particle size ≥95% through 80 mesh USP<786> CAS / formula / MW 446-72-0 · C₁₅H₁₀O₅ · 270.24 — Loss on drying / ash ≤1.0% / ≤1.0% GB 5009.3 / 5009.4 The same botanical — Sophora japonica L. — also yields a wider flavonoid family beyond genistein, which is useful if you source multiple ingredients from one manufacturer: Rutin NF11 95% — a flavonoid for vascular and capillary support. Sophora Japonica Extract Quercetin 95% — a well-known antioxidant and anti-inflammatory flavonoid. Kaempferol 50% and Sophoricoside 20%/50%/98% — additional sophora flavonoids for specialized formulas. Reading the COA beyond the assay Heavy metals — total ≤10 PPM, lead ≤3 PPM, arsenic ≤1 PPM, cadmium ≤1 PPM, mercury ≤0.1 PPM (GB 5009 series). Microbiological limits — total plate count ≤1000 cfu/g, yeast & mold ≤100 cfu/g, with E. coli, Salmonella, and S. aureus negative (GB 4789 series). Non-GMO and non-irradiated status, with no carriers or excipients. Source — extracted from Sophora japonica L. fruit using ethanol and water. 3. Applications: Where Genistein Fits in Your Portfolio Genistein's position as the flagship isoflavone makes it a natural fit for several supplement categories: Women's health and menopause support. As a phytoestrogen, genistein is the compound most buyers reach for when formulating isoflavone-based women's health products. Bone health. Research has focused on isoflavones for supporting bone density in aging populations — a core reason genistein appears in bone-support blends. Antioxidant support. As a polyphenol, genistein contributes antioxidant activity, fitting cleanly into antioxidant and healthy-aging formulas. Compliance note: genistein is a dietary supplement ingredient. Keep finished-product claims within your market's rules — "supports bone health" and "phytoestrogen support" are safer than disease-treatment language. 4. How to Vet a Sophora Japonica Extract Supplier Run shortlisted suppliers through this checklist: Purity spec is explicit. Confirm "genistein 98%" is a single-compound figure by HPLC, not a total-isoflavone blend. HPLC + TLC. Request both the quantitative assay (HPLC) and identification (TLC). Batch-level COA. Covering assay, heavy metals, microbiology, and physical parameters. GMP manufacturing. Ask about GMP-standard production and quality documentation. Traceability. Confirm botanical source (Sophora japonica L.), plant part, and origin. Free sample. A reliable supplier will provide a sample for your own assay. Consistency across flavonoids. If you buy rutin or quercetin alongside genistein, confirm each is standardized independently. 5. Justen's Sophora Japonica Extract Range Justen Biotechnology supplies the full sophora flavonoid spectrum from Sophora japonica L., with a 1 kg MOQ and monthly capacity up to 3 tons on core grades, across three production lines (extraction, solvent extraction, purification–drying–packaging): Product Key spec Internal link Natural Sophora Japonica Extract Genistein 98% SJE058 view product High Purity Sophora Japonica Extract 98% Genistein SJE007 view product Sophora Japonica Extract Genistein SJE103 view product Sophora Japonica Extract Rutin NF11 95% SJE032 / SJE057 view product Sophora Japonica Extract Quercetin 95% SJE033 / SJE056 view product Sophora Japonica Extract Kaempferol 50% SJE034 view product Sophora Japonica Extract Sophoricoside 98% SJE097 view product Need a genistein 98% sample and COA? Tell us your target purity, annual volume, and market — we'll send a free sample, batch COA, and a normalized quote. Request a Free Sample & COA → Whatsapp: +86 18716439113 · Email: sale2@solistree.com

Icariin — the signature flavonoid in Epimedium Herb Extract, better known in the trade as horny goat weed — is one of the most actively sourced botanicals in the men's health and bone-support categories. Yet buyers routinely trip over the same two questions: what the difference is between icariin and icariins, and how to verify a supplier's potency claim before paying for a full batch. This guide walks through the specifications that matter, how the ingredient is used, and a checklist for vetting an Epimedium Extract supplier. If you are buying icariin powder in bulk, these are the details that separate a reliable quote from an expensive mistake. Icariin vs Icariins: What Your Formula Actually Needs This distinction is the single most important thing to get right in icariin sourcing, and it is easy to miss on a data sheet. Icariin is a specific compound — a prenylated flavonol glycoside with CAS 489-32-7, molecular formula C₃₃H₄₀O₁₅, and molecular weight 676.66. When a COA states "Icariin 20%," it means 20% of that one compound, measured by HPLC. Icariins (plural) is a broader term covering the family of icariin-type glycosides in Epimedium. An "Icariins 20%" spec is a total-flavonoid figure, not a single-compound figure. Why this matters: a supplier quoting icariins 20% can appear to match a competitor quoting icariin 20%, while delivering less of the specific compound your label is built around. Before you compare quotes, confirm which one you are being offered and normalize everything to the single-compound icariin figure. Justen's Epimedium Powder line carries both spec types — Icariin 10% and 20%, and Icariins 10% and 20% — so you can match the grade to your formula's claims. Key Specifications: Icariin 10% vs 20% Grades Icariin is standardized at several potencies, each suited to different finished products and cost targets: Grade Typical use Notes for buyers Icariin 10% Multi-ingredient blends, budget capsules Economical entry grade; confirm single-compound icariin by HPLC, not total icariins. Icariin 20% Single-ingredient and premium formulas Industry standard for label claims; request the full COA beyond the assay. Icariins 10% / 20% Total-flavonoid positioning Read the spec carefully — "icariins" is a total figure, not icariin. All grades are extracted from the leaf of Epimedium Brevicornum Maxim (a source also referred to as Epimedium Sagittatum Extract in some markets) using ethanol and water, and supplied as a brown-yellow powder. Reading the COA beyond the assay Assay is only one line. Taking Justen's Icariin 20% (EHE021) as a reference, a complete COA should document: Identification and chemistry. Icariin CAS 489-32-7, molecular formula C₃₃H₄₀O₁₅, molecular weight 676.66, confirmed by TLC. Physical parameters. Brown-yellow powder, ≥95% through 80 mesh (USP<786>), loss on drying ≤5.0% (GB 5009.3), sulphated ash ≤5.0% (GB 5009.4). Heavy metals — lead ≤3 PPM, arsenic ≤1 PPM, cadmium ≤1 PPM, mercury ≤0.1 PPM, total heavy metals ≤10 PPM (GB 5009 series). Microbiological limits — total plate count ≤1000 cfu/g, yeast & mold ≤100 cfu/g, with E. coli, Salmonella, and Staphylococcus aureus all negative (GB 4789 series). Non-GMO and non-irradiated status. How Icariin Extract Is Used: Men's Health, Bone & Beyond Epimedium has a long history in traditional use for vitality and reproductive health, and modern research has focused on several areas: Men's health and vitality. Icariin is the most-studied active in Epimedium for supporting energy and healthy circulation — the reason it anchors so many men's wellness formulas. Bone health. Studies have looked at icariin's role in supporting osteoblast activity, which is why it appears in bone-support and healthy-aging supplements. Antioxidant and adaptogenic support. As a flavonoid, icariin contributes antioxidant activity, and Epimedium is traditionally used as an adaptogen for stress resilience. Compliance note: keep finished-product claims within your market's rules. Icariin is a dietary supplement ingredient — structure-label claims around "supports vitality," "supports bone health," or "antioxidant support," and avoid disease-treatment language. Justen's Epimedium Herb Extract Range Justen Biotechnology supplies the full icariin spectrum from Epimedium Brevicornum leaf, with a 1 kg MOQ and monthly capacity of 1–2 tons. Manufacturing runs on three dedicated lines — extraction, solvent extraction, and purification–drying–packaging — with redundant capacity for on-time delivery: Product Key spec Internal link Epimedium Herb Extract Icariin 20% EHE021 view product Epimedium Herb Extract Icariins 20% EHE044 view product Epimedium Herb Extract Icariin 10% EHE073 view product Epimedium Herb Extract Icariins 10% EHE074 view product Epimedium Herb Extract Icariin Icariins EHE106 view product  

Resveratrol remains one of the most actively sourced botanical ingredients in the nutraceutical industry, yet it is also one of the easiest to get wrong. Two suppliers can both quote you "resveratrol 98%" and deliver powders with meaningfully different active content, purity, and cost. If you buy resveratrol bulk without understanding the difference between total resveratrol and trans-resveratrol — or without asking the right questions up front — you risk overpaying, receiving out-of-spec material, or failing your own finished-product testing. This guide covers the specifications that matter when sourcing resveratrol bulk powder, the factors that drive price, and a checklist for vetting a polygonum cuspidatum extract supplier. Trans-Resveratrol vs Resveratrol: What Matters for Your Formula Resveratrol exists in two isomeric forms: trans-resveratrol and cis-resveratrol. Trans-resveratrol is the biologically active, well-studied form found naturally in Polygonum Cuspidatum Resveratrol (extracted from Japanese knotweed root), red grapes, and red wine. Cis-resveratrol, by contrast, is largely a byproduct of extraction or exposure to light and heat, and contributes little to activity. This is the most important thing to check when sourcing resveratrol. A certificate of analysis (COA) that states only "resveratrol 98%" tells you the total resveratrol content — it does not tell you how much of that is active trans-resveratrol. When comparing suppliers, always ask: What is the trans-resveratrol content, not just total resveratrol? Is the trans-resveratrol figure confirmed by HPLC or a less precise UV method? What is the specification limit for cis-resveratrol impurities? A reputable polygonum cuspidatum extract manufacturer will state trans-resveratrol content explicitly — for example, "trans-resveratrol ≥ 98% by HPLC" — rather than hiding behind an ambiguous total figure. Key Specifications: Understanding Resveratrol Grades (5% to 99%) Resveratrol is marketed across a wide range of standardized grades, each suited to different finished products and cost targets. Understanding this range helps you choose the right grade instead of defaulting to the highest (and most expensive) one. Grade Typical use Notes for buyers Water-soluble resveratrol 5% Beverages, liquid shots, sachets Processed (often cyclodextrin-complexed) for water dispersibility; priced above its low assay would suggest because of the solubility technology. Trans-resveratrol 20% Multi-ingredient blends, capsules on a budget Economical entry grade; confirm trans (not total) assay. Resveratrol 50% (powder or granular) Capsules, tablets, mid-tier formulas Good cost-to-potency balance; granular form improves flow and reduces dust for tablet compression. Natural resveratrol 98% Premium single-ingredient supplements Industry standard for high-potency claims; verify trans ≥ 98% and botanical source (knotweed vs fermentation). Trans-resveratrol 98% / 99% High-end, "clean label" supplements Highest purity; expect the strongest documentation and the highest per-kg price. Justen Biotechnology's resveratrol line spans this full range, including trans-resveratrol 20%, resveratrol 50% (powder and granular), natural resveratrol 98% and 99%, and a water-soluble 5% grade — all extracted from the dried root of Polygonum Cuspidatum Root Extract (Sieb. et Zucc.). Lower grades appear as a brown-yellow to off-white powder, while the 98% and 99% grades are an off-white to white powder. Reading the COA beyond the assay Assay is only one line on a COA. Take Justen's trans-resveratrol 98% (PCE101) as a reference — a complete COA should document far more than the headline number: Identification and chemistry. Resveratrol CAS 501-36-0, molecular formula C₁₄H₁₂O₃, molecular weight 228.24, confirmed by TLC. Heavy metals (lead, arsenic, cadmium, mercury, tested per GB 5009 series) and microbiological limits (total plate count, yeast & mold, E. coli, Salmonella, S. aureus, tested per GB 4789 series). Residual solvents. Resveratrol is extracted with ethyl acetate, ethanol and water, so solvent residue must be checked — particularly for EU markets with strict limits. Loss on drying / moisture and bulk density, which affect fill weight and blending. Particle size / mesh (e.g., 100% through 80 mesh, USP<786>), which affects flowability in capsule and tablet lines. Non-GMO and irradiation status. Confirm the material is non-GMO and non-irradiated, with no carrier or excipients added. What Drives Resveratrol Powder Price per Kg? Resveratrol powder price per kg varies widely — far more than a simple "higher assay = higher price" rule. The main cost drivers are: Assay and trans content. Moving from 50% to 98% requires additional purification steps, raising cost disproportionately. A 98% trans-resveratrol will cost substantially more per kg than a 50% grade, and a genuine 99% more again. Trans vs total assay honesty. A supplier quoting total resveratrol can appear cheaper while delivering less active material. Always normalize quotes to trans-resveratrol per kg to compare fairly. Water-solubility technology. Water-soluble grades carry a premium from complexation or encapsulation processing. Botanical source and processing. Knotweed-root extraction is the cost-effective commercial route; fermentation-derived resveratrol or "natural grape" sourcing commands a premium. Volume and MOQ. Bulk orders (hundreds of kg to multi-ton) meaningfully lower per-kg pricing. Justen's resveratrol MOQ is 1 kg, with monthly capacity up to 3 tons depending on grade — flexible enough for both trial and production volumes. Certifications and documentation. Organic, non-GMO, Kosher/Halal, or additional third-party testing all add cost but may be required by your market. How to Vet a Resveratrol Supplier: A 7-Point Checklist Once you have shortlisted suppliers, use this checklist to separate a qualified manufacturer from a trader: Trans-resveratrol specification is explicit. The supplier should commit to a trans-resveratrol assay, not just total resveratrol. HPLC test method. Confirm the assay method is HPLC (or UPLC), the industry-accepted standard — not a UV method that can overstate potency. Batch-level COA and third-party testing. Request a recent COA and ask whether they support independent third-party lab verification before shipment. GMP / quality systems. Ask about manufacturing under GMP and supporting documentation such as ISO or relevant certifications. Stability data. Trans-resveratrol can degrade with light and heat. Ask for stability data and recommended storage (typically cool, dry, protected from light). Free sample. A reliable supplier will provide a sample for your own in-house or third-party assay before you commit to bulk. Traceability. Confirm botanical origin (knotweed root), country of origin, and that the material is produced by the company you are talking to — not repackaged from an unknown source. Justen's Resveratrol Range at a Glance Product Key spec Internal link Trans-resveratrol 20% Powder PCE064 view product Water-soluble Resveratrol 5% PCE031 view product Resveratrol 50% (powder) PCE003 view product Resveratrol 50% Granular PCE029 view product Natural Resveratrol 98% Powder PCE004 view product Trans-resveratrol 98% PCE101 view product Natural Resveratrol 99% PCE068 view product Polydatin 98% (knotweed glycoside) PCE008 view product Need a resveratrol sample and COA? Tell us your target grade (trans-resveratrol %), annual volume, and market — we'll send a sample, batch COA, and a normalized quote. Request a Free Sample & COA → mobile phone: +86 18716439113Email: sale2@solistree.com

Executive Summary The phytoestrogen supplements market is growing — but not explosively, and not evenly. Global Industry Analysts put the market at roughly US$3.9 billion in 2024, forecast to reach US$4.7 billion by 2030 at a 3.2% CAGR. Strategic Market Research is more bullish: US$4.3 billion in 2024 climbing to US$6.9 billion by 2030 at 8.1%. The spread between those numbers tells you the story: the baseline is solid, but the upside depends on which regions and product categories you target. Metric Value Source Global market (2024) US$3.9–4.3 billion Global Industry Analysts; Strategic Market Research Global market (2030 forecast) US$4.7–6.9 billion Same US market (2024) ~US$1.1 billion Global Industry Analysts China CAGR (2024–2030) 6.2% — fastest among major economies Global Industry Analysts Isoflavones share of category ~57.8% Strategic Market Research Women aged 50+ worldwide 1.0 billion (2019) → 1.4 billion (2030) WHO For a botanical ingredient supplier, the conclusion is simple. Demand is real, the demographic tailwind is documented, and the categories worth supplying are isoflavone-based women's health ingredients — not the long tail of minor phytoestrogen classes. Demand Drivers Aging demographics. The WHO projects the global population of women over 50 will grow from about 1 billion in 2019 to 1.4 billion by 2030 — 400 million additional women entering the stage of life where phytoestrogen products are most considered. I've watched this from the supply side. Ten years ago a "women's health" inquiry meant a generic multivitamin. Now the same buyer asks for a Soybean Extract with a specific isoflavone percentage, a defined genistein/daidzein ratio, and an HPLC COA. The buyer has changed. The spec has changed with it. HRT substitution. Concern about hormone replacement therapy (HRT) — driven by widely publicized clinical findings on associated risks — has pushed a meaningful share of women toward plant-based alternatives. Industry tracking, including data cited by the North American Menopause Society (NAMS), shows a significant increase in supplement sales for menopausal symptoms over the past decade. The key nuance for brands: this is substitution demand, not new demand. The customer already exists. She is just moving from one solution to another, which gives the category built-in stability. The "natural" preference. Plant-derived, non-hormonal, clean-label — these descriptors moved from differentiator to baseline over the last five years. Buyers now ask for standardized botanical extracts with verifiable active content as a matter of course, which is where a supplier's documentation (HPLC, COA, traceability) becomes a selling point rather than a formality. Accumulating clinical validation. Randomized controlled trials have examined isoflavone supplementation for vasomotor symptoms, lipid profiles, and bone density. Results vary by population, dosage, and equol-producer status — but the category has clearly moved from "traditional remedy" to "investigated ingredient." For B2B buyers, that changes what regulators will and won't allow on a label. Regional Growth Analysis North America and Europe dominate today. Asia-Pacific is where the growth is. Region Share (2024) Outlook North America ~36% Largest single market; US ~US$1.1B; mature, slower growth Europe ~29% Established infrastructure; Germany ~1.8% CAGR Asia-Pacific ~27% Fastest-growing; China at 6.2% CAGR Rest of World ~8% Emerging; LatAm and Middle East early-stage North America is the biggest market by a wide margin, but not the fastest. It is mature and well-served — brands win on specification precision and regulatory documentation, not novelty. A standardized extract for the US market needs a complete COA and a defensible structure-function claim position. Europe is disciplined by EFSA and Regulation 1924/2006, under which no phytoestrogen health claims currently hold authorized status. The market values clean, well-documented ingredients but cannot market them aggressively. European buyers are the most documentation-heavy — plan for it. Asia-Pacific is the growth engine. China is forecast at 6.2% CAGR — the fastest among major economies — reaching roughly US$929 million by 2030. Japan and South Korea bring long-established soy traditions, making the region both a large producer and consumer. For suppliers, it is a dual opportunity: source from it, and sell into it. A brand focused only on North America is fighting for share in a mature market; one that adds Asia-Pacific is buying into the growth curve. Ingredient Class Trends Isoflavones dominate the category, and the gap is not close. Class Share Primary Sources Commercial Position Isoflavones ~57.8% Soy, red clover, kudzu The workhorse; mature supply chain, defined markers Lignans ~28.6% Flaxseed, sesame Secondary; blended for complementary profile Coumestans ~13.6% Alfalfa, clover sprouts Minor; rarely standalone The practical implication: the revenue and volume are in isoflavones — soy and red clover. Flaxseed Extract and Puerariae Extract fill complementary niches (lignans and kudzu isoflavones) and are worth carrying for portfolio completeness. But no one builds a business on coumestans. Within isoflavones, soy is the reference standard. Industry-standard Soybean Extract grades span 5% up to 80% isoflavones, including aglycone-type grades (40% and 80%) and a dedicated 80% menopause-positioned grade. Red Clover Extract is typically available at 20% and 40% total isoflavones. The spread matters because different segments want different specifications — and a supplier with a full spectrum can serve a buyer as their line evolves. The trend worth watching: aglycone-type extracts. Buyers increasingly ask for aglycone specs — free-form genistein and daidzein without the glycoside conjugation. It is a specification-level detail that signals a more sophisticated buyer, and it is where the premium pricing lives. Application and Form Trends Capsules still lead, but the category is fragmenting across formats. Form Share (2024) Trend Capsules ~46.9% Dominant; standard fill equipment Powders ~24.7% Growing; drink-mix crossover Gummies ~18.8% Fast-growing; stability challenges Liquids ~9.6% Niche; emulsification needs Two trends deserve attention. First, functional beverages: powder and liquid formats are where phytoestrogens cross into ready-to-drink and drink-mix products — and a beverage-grade ingredient needs water solubility or dispersibility, not just a percentage. Second, cosmetics crossover: phytoestrogens are increasingly marketed into skincare for skin-elasticity claims — a different regulatory environment, buyer, and spec sheet that should be treated as a separate product line. For brands, the format decision is not cosmetic. A gummy and a capsule are different manufacturing problems; a drink mix and a softgel are different stability problems. Choose the ingredient and the format together, and ask the supplier for format-specific data (solubility, heat stability, pH tolerance) before you commit. Regulatory and Certification Landscape Across the US, EU, and Canada, the consistent theme is: evidence does not automatically become a claim. The US allows structure-function claims with a disclaimer but bars disease claims. The EU has no authorized phytoestrogen health claims under Regulation 1924/2006. Canada's NNHPD maintains a soy isoflavone monograph with specific dosage, duration, and form requirements. The competitive consequence: brands can no longer differentiate on marketing language alone, because regulators have narrowed what the language can say. Differentiation has shifted upstream to ingredient quality — standardization, HPLC verification, batch consistency, and documentation. That is where a botanical ingredient supplier with genuine analytical capability wins. KOSHER, HALAL, and NON-GMO documentation likewise expands addressable geography — HALAL into Southeast Asia and the Middle East, NON-GMO into clean-label Western markets. Supply Chain Implications for Buyers Here is the part most market reports skip — and the part that determines whether a brand can execute on the opportunity. The category is heavily supplied by Chinese botanical extract manufacturers. That is not a secret or a problem, but it does mean supply chain diligence determines outcomes more than market analysis does. Three realities buyers should internalize: Specification inflation is common. A "40% isoflavones" claim without a test method is ambiguous — UV reads higher than HPLC because it picks up non-isoflavone phenolics. Always request HPLC with individual compound breakdown. Batch consistency is the real differentiator. A supplier who holds a 40% grade within a validated range, batch after batch, is more valuable than one who hits 40% once. This is the difference between a label claim you can defend and one that drifts. Aglycone and glycoside distinction matters. A buyer specifying "40% isoflavones" without clarifying the aglycone/glycoside profile may receive a product that does not match their formulation intent. Ask for the genistein/daidzein ratio, not just the total. For standardized extract buyers, the recommendation is straightforward: treat the COA as the product, not the paperwork. If a supplier cannot produce a complete COA before the order, find one who can. Request a sample COA to see what a complete one looks like. Strategic Opportunities for Supplement Brands Opportunity 1 — Premium women's health positioning. The fastest-growing segment is Healthy Aging / 40+, where consumers read labels, compare brands, and switch without perceived results. Winning here is a positioning play — verified actives and transparent documentation command higher margins than mass-market wellness. Opportunity 2 — Asia-Pacific market entry. The region is growing at 6%+ with both supply and demand. A brand entering with proper HALAL documentation and a locally credible soy story can ride the fastest growth curve in the category. Opportunity 3 — Functional beverage crossover. Powder and liquid formats are the incremental growth, requiring a water-soluble or dispersible ingredient and a supplier with format-specific stability data. Few suppliers do this well — which is precisely why it is an opportunity. Opportunity 4 — Clean-label, aglycone-positioned premium. Aglycone-type extracts (free-form genistein/daidzein) command premium pricing. Pair with NON-GMO documentation and a traceability story for the ingredient-conscious segment. The common thread: every winning position is downstream of ingredient quality. Conclusion The phytoestrogen market will grow from roughly US$4 billion to between US$4.7 and US$6.9 billion by 2030. The demographic driver — 1.4 billion women over 50 — is documented and irreversible. But growth is not uniform: it concentrates in Asia-Pacific, in isoflavone-based women's health products, and in premium positions backed by verified active content. The brands that capture it will select botanical extracts by specification, not by price — and the suppliers who win will be the ones who can prove what is in the drum. Discuss Your Phytoestrogen Sourcing Strategy — Contact our ingredient team to request Soybean Extract or Red Clover Extract specification sheets, sample COAs, or a technical consultation on entering the phytoestrogen category.

Monk fruit extract and stevia are the two dominant botanical high-intensity sweeteners. Both are zero-calorie, zero-glycemic, plant-derived, and US GRAS — and they are not interchangeable. The comparison that matters is not between two plants. It is between two specifications, and two very different cost and sensory trade-offs. What Each Ingredient Actually Is Monk fruit extract comes from the fruit of Siraitia grosvenorii, grown almost entirely in China's Guangxi region. Its sweetening compounds are mogrosides, with Mogroside V as the dominant and most potent. Commercial grades run from 20–25% Mogroside V (commodity tier) to 50% (high-purity) and ≥80% (isolate). Stevia comes from the leaves of Stevia rebaudiana, grown across multiple regions. Its sweetening compounds are steviol glycosides, primarily Rebaudioside A (Reb A), with Reb M and Reb D as cleaner-tasting but pricier fractions. Grades are specified by Reb A content — 80%, 95%, or 99%. The structural point to remember: monk fruit has one benchmark compound. Stevia has several. That single difference shapes everything downstream — how you specify it, how it tastes, what it costs. Specification Structure Attribute Monk Fruit Extract Stevia Benchmark compound Mogroside V Rebaudioside A (or Reb M/D) Sweetness (vs sucrose) 150–300× 200–350× Common grades 20–25%, 50%, ≥80% Mogroside V 80%, 95%, 99% Reb A Assay method HPLC HPLC The grade determines use rate, taste, and cost far more than the plant it comes from. A 20% Mogroside V Monk Fruit Extract and a 50% one are effectively different ingredients. For monk fruit, the spec is clean — more Mogroside V means cleaner taste. For stevia, switching from Reb A to Reb M changes taste, solubility, and price all at once. Sensory Profile: Where the Decision Is Actually Made Stevia's off-note is a bitter, licorice-like aftertaste that lingers past the sweetness peak. The cause is receptor chemistry — steviol glycosides activate TAS2R bitter taste receptors, a mechanism well documented in sensory science. It is worst in low-purity Reb A and at high use rates. Reb M and Reb D reduce it, but at higher cost and lower water solubility. Mogroside V does not hit the bitter receptors the same way. The result is a clean, rounded sweetness with rapid onset and a short finish — closer to sucrose, with no licorice note and no persistent tail.I've watched formulators switch sweeteners mid-development more times than I can count. It is almost always the aftertaste. In a clear beverage there is nowhere to hide it; in a chocolate or a yogurt, fat and protein do the masking for you.Stevia is cheaper. Monk fruit is cleaner. Everything else is a footnote. Technical Performance Parameter Stevia Monk Fruit Extract Heat stability Up to 200°C Up to 180°C Water solubility ~30 g/L at 20°C ~50 g/L at 20°C pH tolerance 3.0–10.0 2.5–9.0 Aftertaste Licorice/bitter (Reb A) Minimal; sucrose-like The figures are the industry's commonly cited reference values. Stevia tolerates more heat — better for baking and high-temperature pasteurization. Monk fruit dissolves better and tolerates more extreme acidity — better for cold beverages, kombucha, and citrus-heavy RTD products. Neither replaces sugar one-for-one in baked goods; both typically pair with a bulk sweetener like erythritol or allulose there. Cost-in-Use: The Metric That Matters Price per kilogram is the wrong metric. Price per unit of sweetness is the right one.On a per-kg basis, monk fruit extract is the expensive one — bulk pricing runs roughly US80–200/kg, US25–60/kg for stevia, a gap that holds across the industry. The reasons are structural: monk fruit grows in a single Chinese region, and reaching high Mogroside V purity takes more processing steps.But cost-in-use flips when you account for aftertaste. I've had buyers tell me stevia is the cheaper option, then watch their masking-agent budget quietly erase the savings. If stevia's bitterness forces citric acid, flavor modifiers, or a second sweetener into the formula, the "cheap" ingredient stops being cheap.For mass-market soft drinks and energy drinks, stevia's lower bulk cost usually wins. For premium, keto, and clean-label lines where taste is the brand, monk fruit justifies the premium. Regulatory Status Both are broadly cleared, on different timelines. Stevia was approved in the EU in 2011 under Regulation (EU) No 1131/2011, with JECFA setting an ADI of 4 mg/kg body weight. Monk fruit received US FDA GRAS status in 2010 and later EU Novel Food authorization. For multi-market formulators, both work in the US and EU — but the specific grade must match each jurisdiction's approved profile. Application Fit: Where Each Wins Application Better Fit Transparent RTD, citrus, kombucha Monk fruit Premium / keto / clean-label Monk fruit High-heat baking Stevia Mass-market soft drinks Stevia Dairy, confectionery Stevia (or blend) The pattern: monk fruit wins in clean, aqueous, acidic, or premium applications; stevia wins in high-heat, high-volume, or matrix-covered ones. Sourcing Considerations Both ingredients sell across a wide grade range, and the grade — not the plant — determines what you receive. Three checks apply: Specify by the benchmark compound. "Monk fruit extract" without a Mogroside V percentage is ambiguous. Confirm the assay method. HPLC with the individual compound quantified is the standard. Watch for fillers. Some blends pad the active with erythritol or maltodextrin; the COA should state active content explicitly. JustenBio supplies Monk Fruit Extract standardized to Mogroside V — 20%, 30%, and 50% powder grades, all HPLC-assayed and extracted from Siraitia grosvenorii fruit with ethanol and water. Our Standardized Extract products ship with full COA documentation. For beverage lines pairing a natural sweetener with a functional botanical, Green Tea Extract is a common co-ingredient. Conclusion Monk fruit extract and stevia are both legitimate, broadly approved, zero-calorie sweeteners. Monk fruit wins on flavor clarity, solubility, and pH tolerance, and costs more. Stevia wins on heat stability and cost-in-use, and carries an aftertaste you may need to mask. The formulators who get this right are the ones comparing specifications, not plants.

The women's health supplement market has shifted. Buyers no longer want generic herbal blends. They want standardized botanical extracts with verified active compound content, batch-to-batch consistency, and documentation that satisfies regulators in multiple jurisdictions. Phytoestrogens — plant-derived compounds structurally similar to endogenous estrogens — are among the most requested nutraceutical ingredients in this category. For formulators and buyers, the challenge is not whether to use them. It is how to select the right botanical extracts, at the right specification, from a supplier that delivers both quality and traceability. What Are Phytoestrogens? Phytoestrogens are plant secondary metabolites that can bind to mammalian estrogen receptors. They are not hormones — they are phytochemicals that formulators evaluate for potential interaction with estrogen receptor signaling pathways. Class Representative Compounds Common Sources Isoflavones Daidzein, genistein, glycitein, formononetin, biochanin A Soybean, red clover, kudzu Lignans SDG, enterolactone Flaxseed, sesame Coumestans Coumestrol Alfalfa, clover sprouts For botanical supplement formulation, isoflavones dominate commercially: most researched, with established HPLC methods, defined marker compounds, and supply chains mature enough for multi-ton orders. Lignans from flaxseed are secondary — typically added for complementary phytochemical profiles rather than as primary actives. Coumestans are rarely used as standalone ingredients in commercial herbal extracts for supplements. Key Botanical Sources Not all botanical extracts are created equal. The same plant name can conceal huge variation in active content, extraction solvent, and standardization approach. Source Main Actives Typical Specifications Role Soy Isoflavones (genistin, daidzin, glycitin + aglycones) 40% total isoflavones (HPLC); higher grades available Primary active in most women's wellness SKUs Red Clover Isoflavones (formononetin, biochanin A, daidzein,genistein) 8% or 20% total isoflavones (HPLC) Complementary source; broader aglycone profile Kudzu Puerarin, daidzin, daidzein Puerarin 40–98% (HPLC) Niche; puerarin-specific formulations Flax Lignans (SDG) SDG 20–40% (HPLC) Secondary ingredient in blends Soy isoflavones are the category standard. A typical standardized botanical extract spec is 40% total isoflavones by HPLC (60–80% grades exist for specialized applications). Soybean Extract is the most widely sourced standardized extract here. Buyers often overlook composition: a 40% extract is a mixture — genistin/genistein (largest fraction), daidzin/daidzein (second; daidzein is the equol precursor via gut metabolism), and glycitin/glycitein (minor). HPLC quantifies each individually; UV gives a total that can overestimate by 10–30%. For standardized extracts, HPLC is the only acceptable assay. Red Clover Extract contains the same isoflavone classes in a different ratio — formononetin and biochanin A (methylated precursors) dominate, converting to genistein and daidzein in vivo. Its advantages: broader aglycone spectrum and different sourcing geography. The trade-off: 8% or 20% grades require higher milligram doses per serving than soy — calculate on "total active isoflavone" basis, not extract weight. Kudzu's puerarin is chemically distinct. Puerariae Extract is used mainly in cardiovascular and neurological formulations. Flaxseed Extract works via enterolactone/enterodiol gut conversion and fits as a secondary ingredient in broad women's health blends. Ingredient Synergy Formulators rarely use single-ingredient phytoestrogen products. The question is which combinations give complementary profiles without compromising stability or analytical clarity. Rationale Example Pairing Consideration Receptor coverage Soy + red clover isoflavones Different ratios; combined HPLC COA required Mechanism diversification Isoflavones + flax lignans Different pathways; label complexity increases Bioavailability support Isoflavones + phospholipid complex Higher unit cost; premium positioning Micronutrient co-delivery Isoflavones + vitamin D3 + calcium Bone health positioning; stability testing Antioxidant co-delivery Isoflavones + Green Tea Extract Multi-mechanism; adds botanical diversity Each additional botanical multiplies the analytical burden: separate HPLC methods, individual marker tracking, cross-contamination screening, and separate heavy metal/pesticide specs per source. The formulation benefit must justify the overhead. Also evaluate mineral interactions (calcium can form insoluble complexes with isoflavones in aqueous matrices), oxidative stability (omega-3 co-formulation requires oxygen barrier packaging), and pH sensitivity (aglycones are less stable in highly acidic matrices such as effervescent tablets). Why Standardization Matters More Than Extract Ratio This is the section most botanical ingredient buyers get wrong. Feature 20:1 Extract Ratio 40% Standardized Extract What it means 20 kg herb → 1 kg extract Minimum 40% marker compounds by HPLC Batch consistency Variable with crop/season High — held within validated range Analytical requirement TLC identity + physicals HPLC quantification of individual compounds Regulatory defensibility Weak — no compound-specific claim Strong — claims can reference specific actives Price per mg of active Higher (due to variability) Predictable An extract ratio tells you how much raw material was used — nothing about what is in the powder. A 20:1 soy extract might contain 5% isoflavones or 25%. A 40% standardized extract guarantees 40% by HPLC, batch after batch. I've had buyers tell me their "20:1 extract" tested at 8% active. The supplier wasn't wrong — the spec sheet never promised an active percentage. It promised a ratio. That's not fraud. It's just useless. A competent COA for a standardized botanical extract must include: HPLC assay with individual markers (not just a total), heavy metals with specific ppm values (not "conforms"), pesticide screen with method stated, residual solvents (if solvent extraction used), microbiology, and reference standard source/lot numbers. Red flag: "40% isoflavones by UV" without HPLC breakdown is not sufficient for a standardized product. Batch consistency is a manufacturing requirement, not a preference. A 10% variation between batches means label compliance risk and consumer inconsistency. Standardized extracts absorb agricultural variability at the raw material level — the supplier blends, controls extraction parameters, and releases by analysis. Documented chain-of-custody (farm → processing → lab → warehouse) further reduces adulteration and substitution risk. Safety, Evidence, and Regulatory Considerations Scientific evidence does not automatically translate to permissible commercial claims. Frameworks distinguish research findings from what brands may state on labels. US: FDA permits structure-function claims (e.g., "supports hormonal balance") with the required disclaimer. Disease claims ("treats menopause") require drug approval — not permitted for supplements. EU: Regulation 1924/2006 governs nutrition and health claims; no phytoestrogen health claims currently have authorized status. Brands must use general wellness positioning. Canada: NNHPD maintains a soy isoflavone monograph permitting certain claims if dosage, duration, and form requirements are met; a Product License Application is required before marketing. Finished brands bear independent responsibility for label substantiation, target-market compliance, adverse event reporting, and GMP. A botanical ingredient supplier provides the raw material, COA, and regulatory documentation — the brand owns what the finished product claims. Market Positioning Opportunities Positioning Target Ingredient Strategy Price Point Women's Daily Wellness 30–50, preventive Broad blend, 2–4 botanicals, moderate doses $15–25/month Healthy Aging / 40+ 40–55, symptom-aware Standardized extracts, HPLC-verified actives $25–40/month Plant-Based / Clean Label All ages, ingredient-conscious Botanical-only; non-GMO; organic where available $30–50/month Premium Nutraceutical 45+, quality-first Clinically researched specs; third-party tested $40–60/month Healthy Aging is the fastest-growing segment in Western markets — these consumers read labels and switch brands without perceived results, so HPLC data and transparent COA access are competitive advantages. Premium brands often commission custom specifications (specific isoflavone ratios, novel delivery forms) with multi-market regulatory documentation. About JustenBio Justen Biotechnology specializes in research, development, and production of standardized botanical extracts for the supplement and nutraceutical industries. Based in Mianyang, Sichuan, we supply botanical extracts including soy isoflavones, red clover, and custom phytoestrogen ingredients to brands worldwide. Every standardized extract ships with HPLC-based COA, individual marker quantification, heavy metal/pesticide/solvent screening, and GMP-certified manufacturing. Custom specifications available for premium and clinical-grade applications. Request a Sample COA — Contact our ingredient team to discuss your phytoestrogen formulation requirements, request specification sheets, or arrange a virtual facility audit

Why Astragalus Extract Sourcing Is More Complex Than It Looks Astragalus (Astragalus membranaceus) has been used in traditional Chinese medicine for centuries. The modern supplement industry values it for immune modulation. But the gap between "astragalus extract" on a quotation and a product that delivers consistent immune activity is wide. Three active fractions exist in the root. Most suppliers only assay one. Buyers who do not specify which fraction they need — and at what level — receive products with different biological activity from batch to batch. The Three Active Fractions Compound Class Key Marker Typical Content in Root Primary Bioactivity Assay Method Saponins Astragaloside IV 0.1-0.5% Immune modulation, anti-inflammatory, telomerase activation (in vitro) HPLC (UV or ELSD) Polysaccharides Astragalus Polysaccharides (APS) 5-15% in raw root; 30-70% in extract Macrophage activation, NK cell enhancement, complement system stimulation Phenol-sulfuric acid method Flavonoids Calycosin, formononetin 0.1-0.5% Antioxidant, weak estrogenic activity HPLC Most Astragalus Extract on the market is standardized to astragaloside IV because it is the easiest compound to quantify by HPLC. But APS drives a substantial portion of the immune activity. A product with 10% astragaloside IV and low APS content is not the same as a product with 2% astragaloside IV and 60% APS — even though the first looks "stronger" on paper. Mechanism of Action 1. TLR4/NF-κB pathway modulation. Astragaloside IV modulates TLR4/NF-κB signaling in macrophages and dendritic cells, reducing pro-inflammatory cytokine production (TNF-α, IL-6) without the uncontrolled inflammatory cascade seen with TLR4 agonists like LPS (Fu et al., 2014). 2. T-cell and NK cell enhancement. APS increases CD4+ and CD8+ T-cell counts and enhances NK cell cytotoxicity. Animal studies and limited human trials suggest benefit for elderly subjects and athletes under intense training. Specific trial designs and extract compositions vary widely. 3. Telomerase activation (in vitro). TA-65, a commercial astragalus-derived product, claimed telomerase activation based on astragaloside IV research. The in vitro data exist (de Jesus et al., 2011). The human clinical data showing lifespan extension do not. Supplement brands should not structure marketing claims around this mechanism without regulatory counsel review. Clinical Evidence Summary Respiratory Infection Prevention Meta-analyses of RCTs in children suggest astragalus extract may reduce acute respiratory infection frequency by roughly 20-30% versus placebo. The effect appears larger in children with recurrent infections and when the extract is taken for 8+ weeks. Studies used varying extracts (astragaloside IV content not consistently reported), so the dose-response relationship is unclear. Immune Function in Athletes Studies in athletes under intense training report improved CD4+/CD8+ ratio, increased NK cell activity, and lower post-training cortisol with astragalus supplementation. The immune-suppressing effect of intense training appears partially offset. Extracts used in these studies were typically low-dose astragaloside IV (0.3% by UV) at 500 mg/day — not high-potency extracts. Elderly Immune Support Studies in elderly subjects using APS-rich extracts report increases in serum immunoglobulins (IgA, IgG, IgM) and improvements in T-cell subsets. Polysaccharide content may matter more than saponin content for this demographic. Specifications: What the Numbers Mean Specification Grade Code What It Measures Capacity Best For Astragaloside IV 20% ASE102 Astragaloside IV monomer at 20% by HPLC. Confirmed by retention time. 2 ton/month Mid-tier immune supplements. Cost-positioned products requiring verified astragaloside IV content. Astragaloside 30% ASE071 Total astragalosides at 30% by HPLC. 1 ton/month Formulations balancing cost and potency. Entry-level standardized grade. Astragaloside 50% Powder ASE040 Total astragalosides at 50% by HPLC, powder form. 3 ton/month High-volume immune products. Our highest-capacity grade. Astragaloside IV 70% ASE072 Astragaloside IV monomer at 70% by HPLC. High-purity single compound. 2 ton/month Premium formulations and clinical trial materials where monomer purity matters. Astragaloside 98% ASE039 Pure astragaloside by HPLC. Individual compound confirmed by retention time and peak area. 2 ton/month Research-grade applications. High-end formulations with strict monomer specificity. Sourcing issue: A quotation for "Astragalus Extract, 10% astragaloside IV" without the test method is ambiguous. 10% by UV and 10% by HPLC are different products. UV-overstated values are common because UV picks up all saponins, not just astragaloside IV. Request the method. Practical notes: Astragalus Extract powder is hygroscopic. Store sealed with desiccant. Heat stable up to 80°C; prolonged exposure above 90°C degrades astragaloside IV. Water solubility: APS fraction is water-soluble; astragaloside IV is poorly water-soluble. For beverage applications, APS-focused extracts or emulsified astragaloside IV are required. What to Check on a COA Parameter Limit Method Purpose Astragaloside IV Per spec HPLC (preferred) or UV Confirm test method. HPLC required for 98% grade. Astragalus Polysaccharides Per spec Phenol-sulfuric acid Relevant for immune-focused extracts. Often omitted on COAs. Lead (Pb) < 3.0 ppm ICP-MS / AAS Soil contamination. Arsenic (As) < 2.0 ppm ICP-MS / AAS Growing region dependent. Cadmium (Cd) < 1.0 ppm ICP-MS / AAS Fertilizer source. Aflatoxin B1 < 5.0 μg/kg ELISA or HPLC Critical for astragalus — root crops carry higher mycotoxin risk than leaf/stem materials. Total Plate Count < 1,000 CFU/g USP <61> Microbial load. Yeast & Mold < 100 CFU/g USP <61> Storage conditions indicator. E. coli / Salmonella Absent in 10g USP <62> Pathogen screen. Pesticide Residues Per USP <561> or EP GC-MS / LC-MS Required for root-based extracts including Astragalus Extract, Polygonum Cuspidatum Extract, and Puerariae Extract. Often omitted on first-round COAs. Residual Solvents Per USP <467> GC Headspace Ethanol, methanol used in extraction. Loss on Drying < 5.0% USP <731> Moisture content. Two Red Flags Specific to Astragalus 1. Missing aflatoxin B1 data. Astragalus is a root crop grown in soil. Mycotoxin risk is higher than for aerial plant parts. A COA without aflatoxin testing is incomplete for this ingredient. 2. APS content omitted on polysaccharide-focused extracts. If the product is marketed for immune support, the polysaccharide fraction drives much of the activity. The COA should report APS content by phenol-sulfuric acid method. Its absence suggests the supplier does not test for it — or the content is lower than claimed. Formulation Considerations Astragalus extract pairs with other immune modulators. The most common combination in the market is astragalus + Shiitake Extract (mushroom polysaccharides). The mechanisms are complementary: astragaloside IV modulates TLR4/NF-κB signaling, while Shiitake Extract polysaccharides (lentinan) activate dendritic cells through different pathways. The combination produces broader immune coverage than either alone. Other common pairings: astragalus + elderberry (antiviral + immune), astragalus + zinc (T-cell support + direct antiviral). Dose range for immune formulas: 200-500 mg/day of a 10% astragaloside IV extract, or 1,000-2,000 mg/day of a 0.3% extract. Higher-dose APS-focused products use 500-1,000 mg/day of APS 50%+ material. Water solubility is a formulation constraint for astragaloside IV. For ready-to-drink beverages, APS-focused extracts are preferred. For capsules and tablets, standard astragaloside IV extracts work without special handling. Stability and Regulatory Notes Standard storage (cool, dry, sealed): <5% astragaloside IV degradation over 24 months. APS is more stable than saponins. Accelerated testing (40°C/75% RH, 6 months): <8% loss of astragaloside IV. Degradation rates are comparable to other heat-sensitive compounds such as epigallocatechin gallate in Green Tea Extract. Nitrogen-flushed packaging recommended for high-potency extracts. US: Dietary supplement ingredient under DSHEA. Structure-function claims permitted with FDA disclaimer. EU: No authorized health claims for astragalus under Regulation 1924/2006. General wellness language used. Canada: NHP ingredient; claims require PLA approval. Australia: Listed complementary medicine under TGA. Verify claim compliance with regulatory counsel. About Our Astragalus Extract Justen Biotechnology supplies five standard grades of astragalus extract from Astragalus membranaceus (Fisch.) Bunge root: astragaloside IV 20% (ASE102), astragaloside 30% (ASE071), astragaloside 50% powder (ASE040), astragaloside IV 70% (ASE072), and astragaloside 98% (ASE039). All grades are assayed by HPLC. Monthly production capacity ranges from 1 ton (ASE071) to 3 tons (ASE040). Minimum order quantity: 1 kg. Standard packaging: 25 kg/drum. Shipping by ocean or air. Certifications: KOSHER, HALAL, NON-GMO. Full COA per batch: astragaloside IV assay, APS content, heavy metals, aflatoxin B1, pesticides, residual solvents, microbiology. GMP-certified facility. In-house HPLC and UV lab. Virtual or on-site audits available. Other immune ingredients in our catalog include Shiitake Extract, Vine Tea Extract, and Flaxseed Extract. How can I request a sample of astragalus extract for evaluation? Contact our team through the inquiry form or email. Evaluation samples (50-100 g) ship with corresponding COA. 25 kg trial quantities available for pilot production. Request a sample here.

Why "GMP-Certified" Is Not Enough Every botanical extract supplier claims GMP. The certificate looks the same whether the facility was audited last month or three years ago, whether the scope covers your specific product or just general food processing. Buyers who treat "GMP-certified" as a pass/fail checkbox end up with suppliers who look compliant on paper and cut corners in practice. Here's the reality: GMP is a system — documented procedures, controlled environments, verified testing. The certificate is just proof that someone checked the system once. What matters is what happens on a Tuesday afternoon when a raw material batch arrives and the QC lab is backed up. This article covers five production stages and the verification questions that separate real GMP from documentation theater. Stage 1: Raw Material Intake Quality failures in finished extracts usually start here. GMP requires every incoming batch to pass identity verification before entering production. Checkpoint Method What It Detects Botanical Identity Macroscopic examination, microscopic ID, TLC fingerprint Wrong species, adulteration with look-alike plants Foreign Matter Visual inspection, sieving Soil, stones, non-plant material, insect fragments Moisture Content Loss on drying (USP <731>) Excess moisture leading to microbial growth Heavy Metals (Screening) ICP-MS or AAS Lead, arsenic, cadmium, mercury above thresholds Pesticide Screening GC-MS / LC-MS Organophosphates, organochlorines, pyrethroids Aflatoxins HPLC-FLD or ELISA Aflatoxin B1, B2, G1, G2 Gap to watch: Non-GMP facilities often accept supplier-provided documentation without independent verification. A 0% rejection rate for incoming raw materials over 12 months is suspicious — it means either no testing or no standards. Stage 2: Extraction Four parameters must be controlled and documented: Parameter Why It Matters Critical Deviation Solvent Type and Ratio Different compounds extract at different ethanol:water ratios — Epimedium Herb Extract and Soybean Extract require different solvent profiles. Using industrial-grade instead of food-grade ethanol to cut cost. Extraction Temperature Excessive heat degrades heat-sensitive compounds; too low reduces yield. No temperature monitoring; operator adjusts without recording. Extraction Time Under-extraction leaves actives in spent material; over-extraction co-extracts undesirable components. Time determined by convenience rather than validated protocol. Solid-to-Liquid Ratio Too little solvent reduces yield; too much increases concentration cost. Ratio not standardized; varies batch to batch. Every extraction run generates a batch production record (BPR) documenting actual values. Deviations are recorded, investigated, and assessed before batch release. In non-GMP facilities, records are often completed after the fact with nominal values only. Stage 3: Concentration and Drying Concentration uses vacuum evaporation at 50-65°C. The vacuum reduces solvent boiling point, preserving heat-sensitive actives. Non-GMP operations may use atmospheric evaporation at higher temperatures — faster, but degrading actives that broad HPLC specifications might not catch. Drying methods: Spray drying: Industry standard. Controls: inlet/outlet temperature, feed rate, atomizer speed — documented per batch. Vacuum drying: For heat-sensitive extracts. Slower, more expensive. Controls: vacuum level, shelf temperature, drying endpoint (not fixed time). The method should be determined by the compound's thermal stability — Monk Fruit Extract and Green Tea Extract are spray-dried under standard conditions; heat-sensitive compounds may require vacuum drying. GMP facilities validate the method per product, not by equipment availability. Stage 4: Finished Product Testing — The COA The COA is the core quality document. A GMP-compliant COA covers seven categories: Category Tests Method Reference Assay Active compound content (e.g., icariin in Epimedium Herb Extract or resveratrol in Polygonum Cuspidatum Extract) HPLC (in-house validated method) Physical Appearance, odor, particle size, bulk density, loss on drying USP <616>, <731>, <786> Heavy Metals Pb, As, Cd, Hg ICP-MS (USP <233>) Microbiology Total Plate Count, Yeast & Mold, E. coli, Salmonella, S. aureus USP <61>, <62> Pesticides Multi-residue screen (200+ compounds) USP <561> or EP 2.8.13 Residual Solvents Ethanol, methanol, acetone, ethyl acetate USP <467> Identification TLC or HPLC fingerprint match to reference standard USP <203> Red Flags on a COA Missing test categories: A COA reporting assay and physical parameters but omitting heavy metals and microbiology suggests cost-cutting. These are the expensive tests. "Conforms" without numerical results: A legitimate COA reports measured values. "Conforms" with no number means the test was not performed or the result is not being shared. Exception: pass/fail tests. No batch number or date: Traceability is required for audit purposes. Generic or template COAs do not meet GMP requirements. Results exactly at specification limit: If every heavy metal result is exactly at the limit (e.g., 3.0 ppm), the lab is likely reporting the detection limit rather than actual measured values. Stage 5: Facility Infrastructure Element GMP Requirement Purpose Air Handling (HVAC) Filtered air, controlled temperature and humidity, positive pressure in processing areas Prevents cross-contamination; controls moisture absorption Water System Purified water (conductivity <1.3 µS/cm at 25°C); routine microbial monitoring Water is used in extraction and cleaning; contaminated water contaminates every batch Personnel Flow Separated clean/dirty corridors; gowning rooms; documented hygiene procedures Personnel are the largest source of microbial contamination Equipment Cleaning Validated cleaning between product changeovers; cleaning records per batch Residual compounds from a previous product (e.g., Monk Fruit Extract) can contaminate the next batch (e.g., Soybean Extract) GMP vs. Non-GMP: Practical Differences Aspect GMP Facility Non-GMP Facility Documentation Batch records completed in real time, signed, countersigned. Deviations documented. Records completed after the fact, if at all. Generic templates. Raw material segregation Quarantine area pending test results. "Accepted / rejected / quarantine" labeling. Materials move directly to production without testing or status labeling. Calibration All instruments on documented calibration schedule with next-date stickers. Reactive calibration (when something breaks). Pest control Documented program with contractor records, bait station maps, trend analysis. No systematic program. Training Operators trained on SOPs. Training records maintained. On-the-job training only. No documentation. Complaint handling Documented system with root cause analysis, CAPA, trend monitoring. Ad hoc handling. No systematic analysis. Buyer Verification Checklist Use these questions during supplier qualification or facility audit: "Show me the raw material intake log for your most recent batch." (Should include date, supplier, batch number, test results, disposition.) "What is your rejection rate for incoming raw materials over the past 12 months?" (0% is suspicious.) "Do you maintain retained samples, and for how long?" (GMP: at least one year beyond finished product expiry.) "May I review a completed batch production record — actual operator entries, not a blank template?" "Walk me through how you handled a deviation in the past six months." "What solvent grade do you use? Show me the supplier's certificate of conformance." "Which drying method do you use for this extract, and can you show the validation data?" "Do you perform all testing in-house, or use third-party labs? Show me accreditation certificates." "Provide COAs for the three most recent batches." (Assess batch-to-batch consistency.) "What is your out-of-specification (OOS) procedure? How many OOS results in the past year, and how were they resolved?" Planning a supplier audit? We provide a downloadable GMP facility audit checklist covering all 10 verification questions above, plus documentation review templates. Download the audit checklist → About JustenBio's Manufacturing Standards GMP-certified facility. Three extraction lines. Controlled-environment drying. In-house QC lab. Every batch ships with COA covering assay (HPLC), heavy metals (ICP-MS), microbiology (USP <61>/<62>), pesticide residues (GC-MS/LC-MS), and residual solvents (USP <467>). Certifications: KOSHER, HALAL, NON-GMO. Buyer audits welcome — virtual or on-site. Contact us to schedule. How can I schedule a virtual or on-site audit of JustenBio's facility? Contact our team through the inquiry form or email. We offer virtual facility tours via video call and on-site audits at our production facility. Typical virtual audit duration: 60-90 minutes. On-site audits: 1-2 days including production area, QC lab, and document review.

Technical reference for supplement brands, R&D teams, and procurement professionals evaluating soybean extract as a phytoestrogen ingredient. At a Glance: Specifications: 20% UV-grade vs. 40% HPLC-grade — test method determines what the number actually represents. COA checklist: 13 parameters. Verify the test method, individual isoflavone breakdown, and all safety data. Supplier red flags: Genistein:Daidzein ratio outside 5:4:1, missing pesticide data, "Conforms" without measured values. Clinical evidence: 20% reduction in hot flash frequency (54 mg/day median dose), +2.4% lumbar spine BMD (82 mg/day), modest cholesterol reduction. Why Soybean Isoflavones, and Why Sourcing Matters Soybean isoflavones are the most studied phytoestrogen on the market — over 2,000 PubMed-indexed papers. The core problem in sourcing: supplement brands often evaluate clinical data extensively but select suppliers based on a single number on a quotation — for example, "40% isoflavones, $85/kg." That number alone is insufficient. The difference between a properly specified soybean extract and one that claims a percentage on paper shows up in batch-to-batch variability, failed third-party tests, or customer complaints. This article covers the chemical structure, clinical evidence, and what to verify at the sourcing stage. The Three Isoflavones in Soybean Extract Soybean (Glycine max) contains three principal isoflavones: Isoflavone Natural Proportion Estrogenic Activity Note Genistein ~50% Highest Binds preferentially to ER-β. Primary compound behind clinical data. Daidzein ~40% Moderate Converted to equol by gut bacteria in ~30-50% of Western adults and ~50-60% of Asian populations. Glycitein ~10% Lowest Contributes to total isoflavone count; limited independent clinical data. The natural ratio is roughly 5:4:1 (Genistein:Daidzein:Glycitein). If a supplier's HPLC report shows 3:6:1 or 7:2:1, the material may have been blended with another source (red clover, kudzu) or the extraction was tuned for yield over profile integrity. A COA showing "40% isoflavones" with Genistein at barely 20% of the total indicates Daidzein-heavy filler. Always request the individual breakdown. If the supplier cannot provide it, that is a sourcing gap. Mechanism of Action 1. Selective estrogen receptor binding. Genistein and daidzein bind preferentially to ER-β (concentrated in bone, blood vessels, and brain) rather than ER-α (dominant in breast and uterine tissue). This selectivity explains the different risk profile compared to pharmaceutical HRT (Kuiper et al., 1998). 2. Daidzein-to-equol conversion. Roughly 30-50% of Western adults have gut microbes that convert daidzein to equol, a more estrogenic metabolite. Asian populations show higher rates (50-60%). This variable conversion explains inconsistent clinical trial results: equol producers respond, non-producers do not (Setchell et al., 2002). Some formulations now include pre-formed S-equol or probiotic strains to address this. Clinical Evidence Summary Menopause Symptoms--Taku et al. (2012): meta-analysis of 17 RCTs, over 1,600 women, median dose 54 mg/day. Result: 20% reduction in hot flash frequency, 26% reduction in severity vs. placebo. The North American Menopause Society's 2022 position statement acknowledges soy isoflavones as a reasonable option for mild to moderate vasomotor symptoms. Bone Density--Wei et al. (2012): 10 trials, ~900 postmenopausal women, +2.4% lumbar spine BMD at 82 mg/day over 6-12 months. Akhlaghi et al. (2020) confirmed the direction across lumbar spine and femoral neck. The effect was larger in women with low baseline BMD. Cardiovascular and Safety--Tokede et al. (2015): 27 trials, 2,000+ participants, total cholesterol down ~0.10 mmol/L, LDL down ~0.11 mmol/L. On safety: the Shanghai Women's Health Study (73,000+ women, Shu et al., 2009) and Japan Public Health Center study (46,000+ women, Nechuta et al., 2012) both found higher soy intake associated with reduced breast cancer recurrence. Regulatory counsel should review claim language before labeling in any jurisdiction. Specifications: 20% UV vs. 40% HPLC vs. 60%+ The headline number — "40% isoflavones" — is meaningless without the test method. Spec Test Method What It Measures Best For 20% Isoflavones UV Spectrophotometry Total isoflavones as aggregate by absorbance. No differentiation between genistein, daidzein, and glycitein. Multi-ingredient blends where isoflavones are secondary. Value-positioned products. 40% Isoflavones HPLC Each isoflavone quantified individually. Chromatogram shows the genistein:daidzein:glycitein split and any unexpected peaks. Standalone menopause supplements. Clinical trial materials. Premium-positioned products. Standard for serious brands. 60%+ Isoflavones HPLC Higher concentration = less powder per capsule = smaller capsules or more room for co-ingredients. Low-dose formats (1 capsule/day). Products competing on capsule size. Key sourcing issue: Two suppliers offering "40% isoflavones" — one by UV and one by HPLC — may be selling different products. UV does not resolve individual isoflavones and cannot detect UV-absorbing impurities padding the number. HPLC provides the breakdown. 40% HPLC-grade is the standard for most supplement applications. The per-dose cost works, the documentation is solid, and the HPLC chromatogram provides regulatory confidence. 20% UV-grade is a legitimate choice for value-tier products, provided the buyer understands the trade-off. Practical notes: Powder is moderately hygroscopic (0.5-1% flow agent handles capsule filling). For tablets, wet granulation is preferred over direct compression. Heat stability is stable up to ~80°C; above 90°C for more than 30 minutes, malonyl-glucoside conjugates degrade. Request stability data if the manufacturer spray-dries at high inlet temperatures. What to Check on a COA A COA with only an assay number and loss-on-drying is not a quality document. A real COA covers the following: Parameter Limit Method Purpose Assay (Isoflavones) Per spec HPLC or UV Confirm the test method. Lead (Pb) < 3.0 ppm ICP-MS / AAS Soil contamination. Soy is a bioaccumulator. Arsenic (As) < 2.0 ppm ICP-MS / AAS Varies by growing region and irrigation source. Cadmium (Cd) < 1.0 ppm ICP-MS / AAS Phosphate fertilizers are a common source. Mercury (Hg) < 0.1 ppm ICP-MS / AAS Environmental contaminant. Usually negligible for soy. Total Plate Count < 1,000 CFU/g USP <61> High TPC indicates poor drying or post-processing contamination. Yeast & Mold < 100 CFU/g USP <61> High counts suggest moisture exposure. E. coli / Salmonella Absent in 10g USP <62> Pathogen screen. Non-negotiable. Pesticide Residues Per USP <561> or EP GC-MS / LC-MS Suppliers often omit this on first-round COAs. It requires a follow-up request. Residual Solvents Per USP <467> GC Headspace Ethanol, methanol, acetone, ethyl acetate — should be below pharmacopeia limits. Loss on Drying < 5.0% USP <731> Above 5% = paying for water weight + stability problems. Bulk Density 0.40-0.60 g/mL USP <616> Impacts capsule fill weight. Drift = capsule weight drift. Particle Size 95% through 80 mesh USP <786> Too coarse = failed content uniformity in multi-ingredient blends. Need a second opinion on a supplier's COA? Our QC team reviews Certificate of Analysis documents for prospective clients at no charge.  Three Red Flags 1. "Conforms" instead of actual numbers. If the heavy metals section says "Conforms" rather than reporting measured values of Pb, As, Cd, and Hg individually, the testing was not done or the results are not being shared. Exception: pass/fail tests (e.g., E. coli absence) are inherently binary. 2. Results at exactly the limit. If every heavy metal is reported at exactly the limit value (e.g., 3.0 ppm), the lab is likely reporting the detection limit rather than actual measured concentrations. Real measurements have variance. 3. Missing categories. A COA covering assay and physical parameters but omitting pesticides and residual solvents should be questioned. These are the expensive tests to run. Stability and Regulatory Notes Standard storage (cool, dry, sealed, light-protected): <5% degradation over 24 months. Accelerated testing (40°C/75% RH, 6 months): <10% loss. Nitrogen-flushed packaging extends shelf life. For liquid formulations, pH below 4.5 retains isoflavones better than neutral pH. US: Dietary supplement ingredient under DSHEA; structure-function claims permitted with FDA disclaimer. EU: EFSA has not authorized specific health claims — general wellness language is used instead. Canada: NHP license required; 6-12 months for PLA approval. Australia: Listed complementary medicine under TGA. Verify claim compliance with regulatory counsel before finalizing labels. About Our Soybean Extract Standard grade: 40% total isoflavones by HPLC. Raw material: Northeast China soybeans (colder climate, longer growing season, cultivars selected for phytochemical profile). Typical client: supplement brands launching or reformulating menopause products.  Certifications: KOSHER, HALAL, NON-GMO. Every batch ships with full COA: pesticide residues, residual solvents, heavy metals, microbiology, individual isoflavone breakdown by HPLC. GMP-certified facility, three extraction lines, in-house QC lab. Audits available: virtual or on-site. Product specification sheet Contact our sales team through the inquiry form or email.

Deeply engaged in plant extraction, connecting with the global market | The 8th Xi'an Natural Health Raw Materials Exhibition Reopens The 24th edition of CPhI & PMEC China 2026, a three-day premier global pharmaceutical ingredients exhibition, concluded successfully at the Shanghai New International Expo Centre.   As an emerging enterprise based in Zitong, Sichuan, specializing in the production of botanical extracts, Justen Biotechnology Co., Ltd. made its debut appearance at this world-class industry event. The company presented over 20 high-purity standardized botanical extract products to global buyers, engaging with clients from Europe, Southeast Asia, the Middle East, and the domestic market. During the exhibition, the company secured intention orders and established numerous collaboration opportunities, achieving three key milestones in its first participation: enhanced brand exposure, expanded client networks, and diversified channel development. About Us: Rooted in Zitong, Dedicated to Botanical Extracts Justen Biotechnology Co., Ltd. is a modern enterprise situated in the Sichuan Zitong Economic Development Zone, specializing in the research, development, production, and marketing of plant-derived extracts. By utilizing cutting-edge technologies like directed separation, the company has built an integrated technical framework covering every stage from raw material sourcing to final product delivery. With precise regulation of extraction parameters and intelligent manufacturing systems, it ensures high purity and excellent batch-to-batch reproducibility across over 20 botanical products, such as soybean isoflavones, sophoricoside, genistein, resveratrol, and polygonum multiflorum glycoside, capable of meeting the most rigorous demands of both pharmaceutical-grade and food-grade applications.  Qualification Certification: Quality-oriented, Standards-driven Qualification Certification Matrix: Compliance comes first. Comprehensive quality control is the core strength that enables products to enter the global market. It stems from a complete and well-established set of qualifications and strict testing systems; Source material control: Cooperate with GAP standardized planting bases, establish a complete source material traceability ledger, provide non-GMO certification, and ensure that the raw materials are natural and free from pesticide residues from the source; International Export Certification: Complete set of FDA registration, KOSHER Jewish kosher certification, HALAL Halal certification, NON-GMO non-genetically modified certification, compliant with the entry standards of multiple countries in Europe, America and the Middle East. Standardized quality control laboratory: Equipped with HPLC (high performance liquid chromatography), UV (ultraviolet) detector, and a microbiological sterility testing room. For each batch of products, a complete COA (certificate of analysis) test report is issued, strictly controlling the four core indicators of activity content, heavy metals, solvent residues, and microorganisms; Production compliance qualifications: Hold the food SC production license and follow the HACCP and FSSC22000 food safety management standards for production. Core product: Three series, complete chain layout At this CPHI exhibition, we showcased three major advantageous product lines: high purity, stable supply, and customizable specifications. These features were highly recognized by overseas and domestic buyers: The soy isoflavone series are the core raw materials of natural plant estrogens. Various content specifications are available for selection. They are widely used in functional health products, female dietary supplements, and pharmaceutical preparations. Relying on high-quality soy raw materials from the Sichuan-Chongqing region, the extracted products have high activity and low impurities, and the supply is stable over the long term. Huali Jiao extract (Huali Jiao glycoside, catechuin) is the company's flagship product with significant advantages. It is suitable for cardiovascular and cerebrovascular preparations as well as dietary health foods. The company can provide customized high-purity monomers with extremely low batch-to-batch variations, and is highly favored by domestic pharmaceutical factories and foreign trade traders. Polygonum extract (resveratrol) is a popular natural antioxidant raw material covering multiple fields such as food, cosmetics and medicine. The regular inventory is sufficient and flexible orders of various sizes are supported. At the same time, small and high-value-added monomer extracts like astragaloside and rehmanniin are also exhibited on-site to meet the diversified formula development needs of customers. Next stop: The Shanghai exhibition of the 2026 WPE Natural Health Raw Materials Expo in Xi'an comes to an end. The journey of cooperation continues without pause! On August 24th - 26th, 2026, the WPE & WHPE 2026 World Expo of Natural Health Raw Materials is held at the Xi'an International Convention and Exhibition Center. As the core gathering area of the national plant extract industry, Xi'an has nearly 2,000 upstream and downstream enterprises, a complete supply chain, a large number of precise buyers, and multiple industry-leading forums. It is an excellent platform for expanding the domestic northwest market and connecting with foreign trade channels in the second half of the year. 2026 WPE&WHPE Looking ahead: In August 2026, we'll meet again in Xi'an Natural Health Raw Materials World Expo Exhibition Name: WPE & WHPE Event Dates: August 24-26, 2026 Exhibition hall address: Xi'an International Convention and Exhibition Center. Booth number: 1G-03 At that time, we will present our upgraded product system, additional high-purity monomer samples, and improved production capacity plans at the exhibition booth. We sincerely invite both new and existing purchasing customers as well as raw material suppliers to visit Booth 1G-03. Come and negotiate sample trials, bulk purchases, and long-term cooperation on-site!

From June 24th to 26th, Sichuan Zidali Biotechnology Co., Ltd., as a leading manufacturer and technological innovator of plant estrogen products, made its debut at the 23rd World Pharmaceutical Raw Materials China Exhibition and the 18th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition held at the Shanghai New International Expo Center in 2025. This grand event attracted more than 15000 overseas visitors from 166 countries and regions around the world to register, providing a broad platform for communication and cooperation in the pharmaceutical industry. ​ As a high-tech enterprise dedicated to the research and development, production, and sales of plant estrogen products, Zidali Biotechnology is committed to becoming the largest plant estrogen product manufacturer and technology innovation center in China. At this exhibition, the company showcased its comprehensive business system and won the attention of many attendees for its mature industrial chain from production to trade. The company's flagship products - soybean extract, Sophora japonica extract, Polygonum multiflorum extract, grapefruit extract, Sculcap extract, Polygonum cuspidatum extract, Houttuynia cordata extract, Fructus Aurantii extract and other plant extracts - have become the focus of the natural extract exhibition area with their excellent quality and leading extraction technology. These products not only occupy an important position in the domestic market, but are also exported overseas, providing high-quality raw material support for the global health industry. ​ In addition, Zidali Biotechnology actively expanded its new product development matrix and showcased new products such as red clover and flaxseed extract for the first time at the exhibition. The company's R&D team stated that these new products are developed based on in-depth research on market trends and precise grasp of consumer health needs, which will further enrich the company's product system and meet the diverse needs of different customers. ​ During the exhibition, the booth of Zidali Biotechnology attracted a large number of domestic and foreign professional visitors to stop and exchange ideas. The company has reached preliminary cooperation intentions with potential customers from multiple countries and regions such as India, South Korea, and Pakistan, further promoting the internationalization process of the company's products. At the same time, the company has also had in-depth exchanges with many well-known pharmaceutical companies and research institutions in China, laying a solid foundation for future industry university research cooperation. ​ The person in charge of Sichuan Zidali Biotechnology Co., Ltd. stated that this exhibition is an important opportunity for the company to showcase its strength, expand its market, and strengthen communication. By participating in this international event, the company not only showcased the leading level of Chinese plant estrogen products to the world, but also injected new impetus into its own development. In the future, the company will continue to increase research and development investment, constantly innovate, improve product quality and service level, and contribute more to the development of the global health industry. ​ With the continuous promotion of the World Pharmaceutical Raw Materials China Exhibition and the World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition, Sichuan Zidali Biotechnology Co., Ltd. is expected to achieve more results on this international stage, helping China's pharmaceutical industry occupy a more important position in the global industrial chain. ​ Standardized Plant Extract,Plant Extract,Soybean Extract,Standardized Extract.

Recently, industry data and related feedback have shown that the export of plant extracts in the global market is showing strong growth momentum. As consumers' attention to natural and healthy products continues to increase, the market demand for plant-based extracts as core raw materials in industries such as food, medicine, and cosmetics continues to rise. ​ Statistical data shows that in the past year, the export volume of plant extracts in China has significantly increased, reaching over 100 million yuan, setting a new historical high. Traditional markets such as the United States, Japan, and the European Union remain the main sources of demand, while emerging markets such as Southeast Asia and the Middle East are also showing a rapid growth trend in demand for plant extracts. The export volume and value of categories such as menthol, stevia extract, and citrus essential oil have all achieved significant growth. ​ From the perspective of regional development, Shaanxi, as a major province in the plant extract industry, has shown impressive performance in export growth. From January to April, Shaanxi exported 5342 tons of plant extracts, a year-on-year increase of 40.2%, with a value of 698 million yuan, a year-on-year increase of 26.1%. New export breakthroughs are also emerging in other regions, such as the first export of honeysuckle extract in a certain region, and the successful export of siraitia grosvenorii extract in a certain region to the United States, promoting the new development of local "rural foreign trade"; The shiitake mushroom extract from certain regions has been successfully exported overseas, with over a hundred types of local extract products exported and markets covering nearly 40 countries and regions. ​ Relevant departments in various regions actively assist enterprises in exporting. For example, some customs carry out lectures on international trade inspection and quarantine requirements to help enterprises improve their management level; Implement refined management of exported plant extracts according to different uses to avoid unreasonable cost increases; Simplify the registration and approval procedures for export production enterprises, promote the "cloud issuance" of inspection and quarantine certificates, and significantly shorten the business processing time. In addition, local commerce departments actively coordinate multiple departments to solve export problems for enterprises. ​ Industry insiders analyze that the growth in exports of plant extracts is mainly due to the popularization of global health consumption concepts and the widespread use of natural and green raw materials in various industries. At the same time, technological progress has driven the continuous improvement of extraction processes and quality standards, further enhancing the competitiveness of Chinese products in the international market. However, the development of the industry also faces challenges, with significant differences in extraction standards and regulations among different countries and regions. Companies need to invest more effort in addressing compliance issues, and fluctuations in raw material prices also have an impact on cost control and profit margins. ​ Looking ahead to the future, as the demand for plant extracts continues to grow in the global market, Chinese companies are expected to further expand their international market share. However, enterprises still need to increase research and development investment, improve product quality and technological content, closely monitor changes in international regulations and standards, actively respond to market risks, and achieve sustainable development. ​ Concentrated Extract,Cinnamomum Burmannii Bark Extract,Dandelion Root Extract,Grapefruit Extract.